Kolexia
Flechon Aude Oncologie médicale
Flechon Aude
Oncologie médicale
Centre Léon-Bérard
Lyon, France
432 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Carcinomes Tumeurs de la prostate Tumeurs embryonnaires et germinales Tumeurs prostatiques résistantes à la castration Tumeurs de la vessie urinaire Métastase tumorale Tumeurs du testicule Carcinome transitionnel Néphrocarcinome

Collaborateurs

Voir plus
Gravis-Mescam Gwenaelle
Gravis-Mescam Gwenaelle
Centre Paoli-Calmettes, Marseille, France
Fizazi Karim
Fizazi Karim
Gustave-Roussy, Villejuif, France
Barthelemy Philippe
Barthelemy Philippe
Hôpital Civil, Strasbourg, France
Oudard Stephane
Oudard Stephane
Hôpital Européen Georges Pompidou, Paris, France

Industries

Voir plus
Janssen
78 collaboration(s)
Dernière en 2023
Ipsen
31 collaboration(s)
Dernière en 2023
Pfizer
28 collaboration(s)
Dernière en 2023
Astellas
25 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
BISCAY: An Open-Label, Randomised, Multi-Drug, Biomarker-Directed, Multi-Centre, Multi-arm Phase 1b Study in Patients With Muscle Invasive Bladder Cancer (MIBC) Who Have Progressed on Prior Treatment (BISCAY).
Essai Clinique (AstraZeneca)   11 mars 2024
Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancer.
The New England journal of medicine   08 mars 2024
Carcinomes primitifs de l'urètre : Recommandations du comité de cancérologie de L'Association Française d'Urologie.
The French journal of urology   02 mars 2024
PROFILER: Program to Establish the Genetic and Immunologic Profile of Patient's Tumor for All Types of Advanced Cancer
Essai Clinique (Centre Léon-Bérard)   01 mars 2024
Analyse descriptive de la plus grande cohorte mondiale de patients atteints de CPRCm traités en accès précoce par [177Lu]Lu-PSMA-617
10e Journées Francophones de Médecine nucléaire - Biarritz   01 mars 2024
CheckMate 9KD: A Phase 2 Study of Nivolumab in Combination With Either Rucaparib, Docetaxel, or Enzalutamide in Men With Castration-resistant Metastatic Prostate Cancer
Essai Clinique (BMS)   01 mars 2024
Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatments and Combinations in Patients With Urothelial Carcinoma (MORPHEUS-UC): A Phase Ib/II, Open-Label, Multicenter, Randomized Umbrella Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatments and Combinations in Patients With Urothelial Carcinoma (MORPHEUS-UC)
Essai Clinique (Roche)   01 mars 2024
TROPHY U-01: A Phase II Open-Label Study of Sacituzumab Govitecan in Unresectable Locally Advanced/Metastatic Urothelial Cancer
Essai Clinique (Gilead)   20 février 2024
STARTER: A National, Multicenter, Phase III Randomized Controlled Trial to Assess the Impact of a One-year Supervised Physical Activity Program to Reduce Long-term Cancer-related Fatigue in Metastatic Testicular Germ Cell Tumor Patients
Essai Clinique (Centre Léon-Bérard)   20 février 2024
MOST plus: A Two-period, Multicenter, Randomized, Open-label, Phase II Study Evaluating the Clinical Benefit of a Maintenance Treatment Targeting Tumor Molecular Alterations in Patients With Progressive Locally-advanced or Metastatic Solid Tumors
Essai Clinique (Centre Léon-Bérard)   09 février 2024